Vancouver, British Columbia, October 12, 2026 / PRNewswire / -- American News Group Market commentators noted that the S&P 500 index hit a record high on October 6th (Tuesday) and closed the week at 7,811.54 points after rising 0.6% on Friday; the Dow Jones Industrial Average closed at 51,654.95 points, and the Nasdaq Composite Index closed at 27,366.17 points. All three indices recorded gains during the week, despite the 10-year U.S. Treasury yield rising to its highest level since 2002 recently and closing at 5.24% on Friday.

The report indicates that the most active stocks during that week were mainly driven by company news, including a satellite spectrum transaction that impacted wireless operators, an update to a Medicare rating, downgrades to airline performance forecasts, and changes in performance guidance from a consumer goods company. Next week, the market will see September inflation data, as well as the first batch of major third-quarter financial reports.

The article mentions that among the active companies with recent developments in the market this week are: Humana Inc (. NYSE : HUM), Delta Air Lines, Inc (. NYSE : DAL), Peps token issuance, Inc (. NASDAQ : PEP), UnitedHealth Group Incorporated (NYSE : UNH), and Johnson & Johnson (NYSE : JNJ).

The largest single-day fluctuation of the week occurred later on Thursday. Reports indicated that SpaceX agreed to acquire a set of 800 MHz low-frequency spectrum licenses covering the entire United States from Grain Management. This transaction still requires approval from the Federal Communications Commission (FCC) and will support its Starlink Mobile services. According to data from The Associated Press, on Friday, T-Mobile US fell by 13.3%, AT &T fell by 9.8%, and Verizon fell by 8.7%; whereas tower operators Crown Castle and American Tower rose by 15.6% and 9.3%, respectively.

The report suggests that the current market environment remains challenging. The Federal Reserve raised its benchmark interest rate in September, marking the first increase in over three years; crude oil prices have risen above $90 per barrel; a survey conducted by the University of Michigan at the beginning of October indicated that consumers expect an inflation rate of 4.7% for the coming year, up from 4.6% a month earlier.

Next week, the trading days in the bond market will be shortened as Monday falls on Columbus Day, a day off for markets, while the stock market will remain open as usual. The U.S. Bureau of Labor Statistics will release the Consumer Price Index ( CPI ) for September at 8:30 a.m. Eastern Time on October 14th (Wednesday), followed by the Producer Price Index ( PPI ) on Thursday. Several of the largest banks in the United States will begin releasing their third-quarter financial results on Tuesday, and two of the largest healthcare companies in the market will also announce their financial reports.

The following are the industry developments and company progress mentioned in the text:

Humana Inc. ( NYSE : HUM )

Humana Shares rose 11.6% on Friday. The company stated that, according to the final 2027 Medicare Advantage star rating data released by the Centers for Medicare & Medicaid Services ( CMS ) on October 8th, the company has surpassed its goal of "reaching the top quartile." Humana mentioned that 95% of its Medicare Advantage members' plans are expected to receive a 4-star or higher rating in 2027. The company reiterated that its adjusted earnings per share guidance for 2026 is at least $9.00 and scheduled an online investor update meeting for December 10, 2026.

Humana CEO Jim Rechtin stated: "We will continue to look for new and better ways to support our members and improve their experience."

Delta Air Lines, Inc. (NYSE : DAL)

Delta Air Lines reported that in the third quarter of 2026, earnings per share after adjustments were $1.72, and according to U.S. Generally Accepted Accounting Principles (GAAP), earnings per share were $1.15; GAAP revenue was $20.2 billion, with pre-tax profit after adjustments amounting to $1.5 billion. The company currently expects earnings per share for the full year of 2026 to be between $5.10 and $5.60, with free cash flow of approximately $2.5 billion, and anticipates that revenue in the December quarter will grow by about 20%. The stock rebounded from its morning decline and closed almost flat on Friday.

Delta Air Lines CEO Ed Bastian stated, "Demand remains strong, supported by consumers' growing expectations for experience and travel preferences." He also added that the company expects to "achieve pre-tax profits of about $4.5 billion while absorbing an increase in fuel costs of $6 billion."

Peps Token Issuance, Inc. (NASDAQ : PEP)

PepsiCo reported on October 8 that its net revenue for the third quarter of 2026 was $25.27 billion, a year-on-year increase of 5.6%; organic revenue grew by 3.1%. Earnings per share increased by 17% to $2.23, and core earnings per share increased by 2% to $2.34. The company raised its full-year organic revenue growth forecast to around 3%, while lowering its core earnings per share growth forecast to a range of 2.5% to 3.5%.

UnitedHealth Group Incorporated ( NYSE : UNH )

UnitedHealth Group will release its third-quarter 2026 financial results before the opening market on October 13 (Tuesday) and will hold a conference call at 8:00 a.m. Eastern Time. In its second-quarter report, the company disclosed that revenue amounted to $112 billion, with an adjusted earnings per share of $6.38, and a medical cost ratio of 86.7%, which is lower than the 89.4% from the same period last year; at the same time, it raised its forecast for adjusted earnings per share in 2026 to $19.50 to $20.00.

The company's CEO, Stephen Hemsley, stated at the time: "Our performance and outlook reflect that we are making continuous progress in simplifying our operations."

Johnson & Johnson (NYSE : JNJ)

Johnson & Johnson will release its third-quarter 2026 financial results on Tuesday, October 13th, at approximately 6:45 a.m. Eastern Time, and will hold an investor conference call at 8:30 a.m. The company's sales in the second quarter were $25.3 billion, a year-over-year increase of 6.6%. Johnson & Johnson has raised its guidance for 2026 earnings as follows: based on the median estimate, it expects reported sales to be $101.1 billion and adjusted earnings per share to be $11.68.

It is disclosed at the end of the article that this piece was published by American News Group. This institution is wholly owned and operated by Market Equities Limited (which is in turn owned by MEL). The article states that this is an independent market commentary and not paid advertising; MEL has not received any fees from any of the companies mentioned in the article for the production or distribution of this content, and these companies have not reviewed or approved it. The article also notes that Market Equities and its owners, operators, directors, and related parties may occasionally hold positions in the securities mentioned in the article or in broad market index funds that track such securities, and retain the right to buy, sell, or hold these securities at any time without prior notice.

The disclosure also states that the information in the text comes from sources considered reliable, including company press releases, SEC documents, government release schedules, and public market price reports, but the accuracy of this information cannot be guaranteed. References to relevant companies in the text are merely provided as market context, as well as an overview of each company's own public disclosures and public market reports, and do not constitute any advice to buy, sell, or hold any securities. The executive statements quoted in the text are reprinted from the relevant company press releases; the stock price fluctuation data cited comes from reports by The Associated Press during the trading period on October 9, 2026; the mentioned release times and dates are based on announcements by various companies and the U.S. Bureau of Labor Statistics and may change; the aforementioned spectrum transactions still require regulatory approval.

In addition, the text reveals that Stock Preachers and its market report "The Roadmap" are also owned by MEL. Mention of these in this article constitutes promotion of related products. The text also reminds readers that Stock Preachers is not a brokerage dealer, and its website, "The Roadmap", or any content within this article does not constitute financial, investment, tax, or legal advice, and is intended solely for informational and educational purposes. At the end of the article, it is noted that this text may contain forward-looking statements, and actual results may differ significantly; readers should refer to the documents submitted by each company to SEC.